{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:13:36Z","timestamp":1785932016410,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jcms.2025.08.010","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:18:17Z","timestamp":1755861497000},"page":"1911-1915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ameloblastoma: The association of BRAF V600E expression with clinicopathological characteristics and treatment outcomes in a case series"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-9853","authenticated-orcid":false,"given":"S.","family":"Crimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ronsivalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cicci\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9374-2748","authenticated-orcid":false,"given":"A.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcms.2025.08.010_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jcms.2010.05.010","article-title":"Delayed soft tissue recurrence after treatment of ameloblastoma in a black African: case report and review of the literature","volume":"39","author":"Adebayo","year":"2011","journal-title":"J. Cranio-Maxillofacial Surg."},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13256-019-2140-6","article-title":"Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report","volume":"13","author":"Broudic-Guibert","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jcms.2025.08.010_bib3","doi-asserted-by":"crossref","DOI":"10.4137\/BIC.S29329","article-title":"Ameloblastoma: a review of recent molecular pathogenetic discoveries","volume":"7s2","author":"Brown","year":"2015","journal-title":"Biomarkers Cancer"},{"key":"10.1016\/j.jcms.2025.08.010_bib4","first-page":"19","article-title":"Ameloblastoma: a review of recent molecular pathogenetic discoveries","volume":"7","author":"Brown","year":"2015","journal-title":"Biomarkers Cancer"},{"issue":"12","key":"10.1016\/j.jcms.2025.08.010_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23206","article-title":"Efficiency of B-RAF-\/MEK-inhibitors in B-RAF mutated Ameloblastoma: case report and review of literature","volume":"9","author":"B\u00fcttner","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-017-0425-1","article-title":"Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers","volume":"9","author":"Callari","year":"2017","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1535-7163.MCT-10-0799","article-title":"BRAFV600E: implications for carcinogenesis and molecular therapy","volume":"10","author":"Cantwell-Dorris","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.joms.2005.11.032","article-title":"The ameloblastoma: primary, curative surgical management","volume":"64","author":"Carlson","year":"2006","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"26","key":"10.1016\/j.jcms.2025.08.010_bib9","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in Melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib10","doi-asserted-by":"crossref","first-page":"djw190","DOI":"10.1093\/jnci\/djw190","article-title":"Durable treatment of ameloblastoma with single agent BRAFi re: clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"109","author":"Faden","year":"2017","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1186\/s12885-018-4802-y","article-title":"Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation","volume":"18","author":"Fernandes","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/his.13095","article-title":"BRAF-V600E expression correlates with ameloblastoma aggressiveness","volume":"70","author":"Fregnani","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.jcms.2025.08.010_bib13","author":"Grynberg"},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0022034518798810","article-title":"The mutational profile of unicystic ameloblastoma","volume":"98","author":"Heikinheimo","year":"2019","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12105-022-01425-w","article-title":"Update from the 5th edition of the World Health Organization classification of head and neck tumors: soft tissue tumors","volume":"16","author":"Jo","year":"2022","journal-title":"Head Neck Pathol."},{"issue":"8","key":"10.1016\/j.jcms.2025.08.010_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijom.2006.02.016","article-title":"Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review","volume":"35","author":"Lau","year":"2006","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2025.08.010_bib17","article-title":"The role of BRAF inhibitors in the management of ameloblastoma: a literature review","volume":"15","author":"Malakar","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.jcms.2025.08.010_bib18","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/prosthesis6060093","article-title":"Prosthetically driven approach to post-ablative maxilla rehabilitation with an implant-supported overdenture: a case report","volume":"6","author":"Malgaj","year":"2024","journal-title":"Prosthesis"},{"issue":"6","key":"10.1016\/j.jcms.2025.08.010_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0b013e3181573e59","article-title":"Ameloblastoma","volume":"30","author":"Mendenhall","year":"2007","journal-title":"American Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/j.jcms.2025.08.010_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-022-01105-8","article-title":"The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma","volume":"35","author":"Mendez","year":"2022","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.jcms.2025.08.010_bib21","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/S1470-2045(14)70072-5","article-title":"Systemic treatment for <em>BRAF<\/em>-mutant melanoma: where do we go next?","volume":"15","author":"Menzies","year":"2014","journal-title":"Lancet Oncol."},{"issue":"C","key":"10.1016\/j.jcms.2025.08.010_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0301-0503(85)80021-7","article-title":"The ameloblastoma, the controversial approach to therapy","volume":"13","author":"M\u00fcller","year":"1985","journal-title":"J. Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1067\/moe.2002.119517","article-title":"Comparison of long-term results between different approaches to ameloblastoma","volume":"93","author":"Nakamura","year":"2002","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib24","first-page":"e70","article-title":"Surgical management of ameloblastoma. Review of literature","volume":"11","author":"Neagu","year":"2019","journal-title":"Journal of Clinical and Experimental Dentistry"},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib25","first-page":"215","article-title":"BRAFV600E-Mutant metastatic colorectal cancer: current evidence, future directions, and research priorities","volume":"23","author":"Piercey","year":"2024","journal-title":"Clin. Colorectal Cancer"},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib26","first-page":"215","article-title":"BRAFV600E-Mutant metastatic colorectal cancer: current evidence, future directions, and research priorities","volume":"23","author":"Piercey","year":"2024","journal-title":"Clin. Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.jcms.2025.08.010_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in Melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jcms.2025.08.010_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bjoms.2006.08.023","article-title":"Effectiveness of a new decisional algorithm in managing mandibular ameloblastomas: a 10-years experience","volume":"45","author":"Sammartino","year":"2007","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.jcms.2025.08.010_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/1097-0142(197402)33:2<324::AID-CNCR2820330205>3.0.CO;2-U","article-title":"Ameloblastoma of maxilla and mandible","volume":"33","author":"Sehdev","year":"1974","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jcms.2025.08.010_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1445-2197.2009.05061.x","article-title":"Mandibular ameloblastoma: clinical experience and literature review","volume":"79","author":"Sham","year":"2009","journal-title":"ANZ J. Surg."},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib31","article-title":"Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: an institutional study","volume":"22","author":"Shirsat","year":"2018","journal-title":"J. Oral Maxillofac. Pathol."},{"issue":"3, Suppl. ment","key":"10.1016\/j.jcms.2025.08.010_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jormas.2024.101846","article-title":"Exploiting BRAF mutations in the therapeutic approach towards oral and maxillofacial tumors","volume":"125","author":"Yi","year":"2024","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib33","doi-asserted-by":"crossref","DOI":"10.4103\/ijdr.ijdr_456_22","article-title":"Effectiveness of molecular-targeted chemotherapy in ameloblastomas: a systematic review","volume":"33","author":"Yoithapprabhunath","year":"2022","journal-title":"Indian J. Dent. Res."},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jop.12807","article-title":"Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: a review","volume":"48","author":"You","year":"2019","journal-title":"J. Oral Pathol. Med."},{"issue":"3","key":"10.1016\/j.jcms.2025.08.010_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jop.12807","article-title":"Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: a review","volume":"48","author":"You","year":"2019","journal-title":"J. Oral Pathol. Med."}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518225002690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518225002690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:00:54Z","timestamp":1757509254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518225002690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1010518225002690"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2025.08.010","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ameloblastoma: The association of BRAF V600E expression with clinicopathological characteristics and treatment outcomes in a case series","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2025.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Association for Cranio-Maxillo-Facial Surgery.","name":"copyright","label":"Copyright"}]}}